308 related articles for article (PubMed ID: 29629903)
1. ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis.
Chen Y; Zhang B; Bao L; Jin L; Yang M; Peng Y; Kumar A; Wang JE; Wang C; Zou X; Xing C; Wang Y; Luo W
J Clin Invest; 2018 May; 128(5):1937-1955. PubMed ID: 29629903
[TBL] [Abstract][Full Text] [Related]
2. CHD4 Promotes Breast Cancer Progression as a Coactivator of Hypoxia-Inducible Factors.
Wang Y; Chen Y; Bao L; Zhang B; Wang JE; Kumar A; Xing C; Wang Y; Luo W
Cancer Res; 2020 Sep; 80(18):3880-3891. PubMed ID: 32699137
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-dependent downregulation of hypoxia-inducible factor (HIF)-2α in invasive breast cancer cells.
Fuady JH; Gutsche K; Santambrogio S; Varga Z; Hoogewijs D; Wenger RH
Oncotarget; 2016 May; 7(21):31153-65. PubMed ID: 27105516
[TBL] [Abstract][Full Text] [Related]
4. HIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets.
Shah T; Krishnamachary B; Wildes F; Mironchik Y; Kakkad SM; Jacob D; Artemov D; Bhujwalla ZM
Oncotarget; 2015 Sep; 6(29):28104-19. PubMed ID: 26305551
[TBL] [Abstract][Full Text] [Related]
5. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
6. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
[TBL] [Abstract][Full Text] [Related]
7. Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression.
Regan Anderson TM; Peacock DL; Daniel AR; Hubbard GK; Lofgren KA; Girard BJ; Schörg A; Hoogewijs D; Wenger RH; Seagroves TN; Lange CA
Cancer Res; 2013 Sep; 73(18):5810-20. PubMed ID: 23928995
[TBL] [Abstract][Full Text] [Related]
8. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
Carroll VA; Ashcroft M
Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression.
Cho KH; Yu SL; Cho DY; Park CG; Lee HY
BMC Cancer; 2015 Oct; 15():829. PubMed ID: 26520789
[TBL] [Abstract][Full Text] [Related]
10. Differential roles of Sirt1 in HIF-1α and HIF-2α mediated hypoxic responses.
Yoon H; Shin SH; Shin DH; Chun YS; Park JW
Biochem Biophys Res Commun; 2014 Jan; 444(1):36-43. PubMed ID: 24423936
[TBL] [Abstract][Full Text] [Related]
11. UBE3B promotes breast cancer progression by antagonizing HIF-2α degradation.
Wang Y; Liu X; Wang M; Wang Y; Wang S; Jin L; Liu M; Zhou J; Chen Y
Oncogene; 2023 Nov; 42(46):3394-3406. PubMed ID: 37783786
[TBL] [Abstract][Full Text] [Related]
12. PRDX2 and PRDX4 are negative regulators of hypoxia-inducible factors under conditions of prolonged hypoxia.
Luo W; Chen I; Chen Y; Alkam D; Wang Y; Semenza GL
Oncotarget; 2016 Feb; 7(6):6379-97. PubMed ID: 26837221
[TBL] [Abstract][Full Text] [Related]
13. Dual histone reader ZMYND8 inhibits cancer cell invasion by positively regulating epithelial genes.
Basu M; Sengupta I; Khan MW; Srivastava DK; Chakrabarti P; Roy S; Das C
Biochem J; 2017 May; 474(11):1919-1934. PubMed ID: 28432260
[TBL] [Abstract][Full Text] [Related]
14. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
15. Expressions of individual PHDs associate with good prognostic factors and increased proliferation in breast cancer patients.
Peurala E; Koivunen P; Bloigu R; Haapasaari KM; Jukkola-Vuorinen A
Breast Cancer Res Treat; 2012 May; 133(1):179-88. PubMed ID: 21877141
[TBL] [Abstract][Full Text] [Related]
16. A SUMOylation-dependent HIF-1α/CLDN6 negative feedback mitigates hypoxia-induced breast cancer metastasis.
Jia Y; Guo Y; Jin Q; Qu H; Qi D; Song P; Zhang X; Wang X; Xu W; Dong Y; Liang Y; Quan C
J Exp Clin Cancer Res; 2020 Feb; 39(1):42. PubMed ID: 32093760
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth.
Nakazawa MS; Eisinger-Mathason TS; Sadri N; Ochocki JD; Gade TP; Amin RK; Simon MC
Nat Commun; 2016 Feb; 7():10539. PubMed ID: 26837714
[TBL] [Abstract][Full Text] [Related]
18. ZMYND8 is a primary HIF coactivator that mediates breast cancer progression.
Chen Y; Wang Y; Luo W
Mol Cell Oncol; 2018; 5(4):e1479619. PubMed ID: 30250924
[TBL] [Abstract][Full Text] [Related]
19. Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression.
Liu J; Zhang C; Zhao Y; Yue X; Wu H; Huang S; Chen J; Tomsky K; Xie H; Khella CA; Gatza ML; Xia D; Gao J; White E; Haffty BG; Hu W; Feng Z
Nat Commun; 2017 Nov; 8(1):1823. PubMed ID: 29180628
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation of the Prox1 gene by HIF-1α and HIF-2α in response to hypoxia.
Zhou B; Si W; Su Z; Deng W; Tu X; Wang Q
FEBS Lett; 2013 Mar; 587(6):724-31. PubMed ID: 23395615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
